Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. ALKEM LABORATORIES LIMITED (D.N.J. 2016)
✉ Email this page to a colleague
OTSUKA PHARMACEUTICAL CO., LTD. v. ALKEM LABORATORIES LIMITED (D.N.J. 2016)
| Docket | ⤷ Try a Trial | Date Filed | 2016-09-26 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-08-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | None | Referred To | Karen M. Williams |
| Patents | 8,017,615; 8,580,796; 8,642,760; 9,359,302 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. ALKEM LABORATORIES LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for OTSUKA PHARMACEUTICAL CO., LTD. v. ALKEM LABORATORIES LIMITED (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-08-23 | 36 | of U.S. Patent No. 8,017,615 (“the ’615 patent”), U.S. Patent No. 8,580,796 (“the ’796 patent”), U.S. …. Patent No. 8,642,760 (“the ’760 patent”) and U.S. Patent No. 9,359,302 (“the ’302 patent”) (collectively…collectively, the “Otsuka Patents”) against Alkem in the present actions. 2. Plaintiff has alleged that the…the Otsuka Patents Would be infringed by any manufacture, sale, offer for sale, use or importation in the…will be enjoined until expiration of the Otsuka Patents from (i) making, using, offering to sell, selling | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
